Ingalls & Snyder LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,250
| Closed | -$10K | – | 439 |
|
|
2020
Q4 | $10K | Sell |
14,250
-88,926
| -86% | -$62.4K | ﹤0.01% | 407 |
|
|
2020
Q3 | $232K | Buy |
103,176
+125
| +0.1% | +$281 | 0.02% | 323 |
|
|
2020
Q2 | $369K | Sell |
103,051
-235
| -0.2% | -$841 | 0.02% | 288 |
|
|
2020
Q1 | $392K | Sell |
103,286
-1,563
| -1% | -$5.93K | 0.03% | 279 |
|
|
2019
Q4 | $316K | Buy |
+104,849
| New | +$316K | 0.02% | 307 |
|